Variability in the performance characteristics of IgG anti-HEV assays and its impact on reliability of seroprevalence rates of hepatitis E

Journal of Medical Virology

Volumn 89, Issue 6, 2017, Pages 1055-1061

  Kodani, Maja ^a   Kamili, Nourine A ^a   Tejada Strop, Alexandra ^a   Poe, Amanda ^a   Denniston, Maxine M ^a   Drobeniuc, Jan ^a   Kamili, Saleem ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

enzyme assays; hepatitis E virus; IgG anti HEV; protein electrophoresis; seroprevalence

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; HEPATITIS ANTIBODY;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; LIMIT OF DETECTION; SEROCONVERSION; SEROPREVALENCE; WESTERN BLOTTING; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; PROCEDURES; REPRODUCIBILITY; SEROEPIDEMIOLOGY; SEROLOGY;

HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; IMMUNOGLOBULIN G; REPRODUCIBILITY OF RESULTS; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS;

EID: 85007319859     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24741     Document Type: Article

References (30)

1. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis. 2010; 202:825–834.
2. Lee GH, Tan BH, Chi-Yuan Teo E, Lim SG, Dan YY, Wee A, Kim Aw PP, Zhu Y, Hibberd ML, Tan CK, Purdy MA, Teo CG. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016; 150:355–357.
3. Miyashita K, Kang JH, Saga A, Takahashi K, Shimamura T, Yasumoto A, Fukushima H, Sogabe S, Konishi K, Uchida T, Fujinaga A, Matsui T, Sakurai Y, Tsuji K, Maguchi H, Taniguchi M, Abe N, Fazle Akbar SM, Arai M, Mishiro S. Three cases of acute or fulminant hepatitis E caused by ingestion of pork meat and entrails in Hokkaido, Japan: zoonotic food-borne transmission of hepatitis E virus and public health concerns. Hepatol Res. 2012; 42:870–878.
4. Teo CG. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect. 2010; 16:24–32.
5. Smith DB, Simmonds P, Izopet J, Oliveira-Filho EF, Ulrich RG, Johne R, Koenig M, Jameel S, Harrison TJ, Meng XJ, Okamoto H, van der Poel WH, Purdy MA. Proposed reference sequences for hepatitis E virus subtypes. J Gen Virol. 2016; 97:537–542. DOI: 10.1099/jgv.0.000393
6. Smith DB, Simmonds P. International committee on taxonomy of viruses hepeviridae study G, Jameel S, Emerson SU, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. Consensus proposals for classification of the family hepeviridae. J Gen Virol. 2014; 95:2223–2232.
7. Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011; 54:2218–2226.
8. Holla RP, Ahmad I, Ahmad Z, Jameel S. Molecular Virology of Hepatitis E virus. Semin Liver Dis. 2013; 33:3–14.
9. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991; 185:120–131.
10. Khuroo MS, Khuroo MS, Khuroo NS. Hepatitis E: discovery, global impact, control and cure. World J Gastroenterol. 2016; 22:7030–7045.
11. Thomas DL, Yarbough PO, Vlahov D, Tsarev SA, Nelson KE, Saah AJ, Purcell RH. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol. 1997; 35:1244–1247.
12. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the third national health and nutrition examination survey, 1988-1994. J Infect Dis. 2009; 200:48–56.
13. Teshale EH, Denniston MM, Drobeniuc J, Kamili S, Chong-Gee T, Holmberg SD. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010. J Infect Dis. 2015; 211:366–373. DOI: 10.1093/infdis/jiu466
14. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a Re-Evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010; 82:799–805.
15. Pas SD, de Man RA, Mulders C, Balk AH, van Hal PT, Weimar W, Koopmans MP, Osterhaus AD, van der Eijk AA. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 2012; 18:869–872.
16. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol. 2013; 56:62–64.
17. Wu WC, Su CW, Yang JY, Lin SF, Chen JY, Wu JC. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. J Med Virol 2014; 86:720–728.
18. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, Novak RT, Sharapov UM, Tohme RA, Teshale E, Kamili S, Teo CG. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis. 2013; 19:218–222.
19. Dong C, Meng J, Dai X, Liang JH, Feagins AR, Meng XJ, Belfiore NM, Bradford C, Corn JL, Cray C, Glass GE, Gordon ML, Hesse RA, Montgomery DL, Nicholson WL, Pilny AA, Ramamoorthy S, Shaver DD, Drobeniuc J, Purdy MA, Fields HA, Kamili S, Teo CG. Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol. 2011; 49:4164–4172.
20. Mast EE, Alter MJ, Holland PV, Purcell RH. Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody Serum panel evaluation group. Hepatology. 1998; 27:857–861.
21. Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Recher C, Izopet J. Low risk of hepatitis e virus reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2012; 54:152–155.
22. Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. Performance of two commercial assays for detecting hepatitis e virus RNA in acute or chronic infections. J Clin Microbiol. 2013; 51:1913–1916.
23. Abravanel F, Chapuy-Regaud S, Lhomme S, Miedouge M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. J Clin Virol. 2013; 58:624–628.
24. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol. 2015; 87:1934–1939.
25. Khan A, Tanaka Y, Kurbanov F, Elkady A, Abbas Z, Azam Z, Subhan A, Raza S, Hamid S, Jafri W, Shih J, Xia N, Takahashi K, Mishiro S, Mizokami M. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol. 2011; 83:622–629.
26. Park HK, Jeong SH, Kim JW, Woo BH, Lee DH, Kim HY, Ahn S. Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays. BMC Infect Dis. 2012; 12:142.
27. Pas SD, Streefkerk RH, Pronk M, de Man RA, Beersma MF, Osterhaus AD, van der Eijk AA. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J Clin Virol. 2013; 58:629–634.
28. Traore KA, Rouamba H, Nebie Y, Sanou M, Traore AS, Barro N, Roques P. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in burkina faso. PLoS ONE. 2012; 7:e48125.
29. Vernier M, Rossi-Tamisier M, Richet H, Brouqui P, Parola P, Bouamri Y, Colson P, Gautret P. Anti-hepatitis E virus antibody prevalence in French expatriate workers. Int J Infect Dis. 2013; 17:e1082–e1084.
30. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis. 2013; 207:497–500.